News

Company shares doubled on Phase 2 study results suggesting its drug could become an alternative to vaccines for flu ...
Based on the cost–effectiveness threshold of £30,000 or $40,000 per QALY, antiviral therapies can be recommended for influenza treatment and post-exposure prevention in healthy and high-risk ...
A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...
Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and ...
Recommendations for the Prevention and Treatment of Influenza Using Antiviral Drugs Based on Cost–Effectiveness Pedro Plans Disclosures Expert Rev Pharmacoeconomics Outcomes Res. 2008;8 (6):563-573.
When the seasonal flu strikes, most people expect the familiar lineup of fever, aches and congestion. But for many patients, dizziness emerges as an ...
Nektar Therapeutics said its embattled immune drug rezpeg significantly improved skin clearance rates in patients with atopic ...
CDC advisory committee recommends thimerosal-free influenza vaccines for all adults and children, despite claims that the ...
With this year's influenza season off to an early start and showing signs of being particularly aggressive, the EU has extended the approved uses of Roche's antiviral Xofluza to include treatment ...
Currently, there are no urgent situations ongoing. The Foreign Office says that "civil disturbance and violent demonstrations ...
Key health updates involve Brazil's bird flu trade restrictions, Nestle USA's removal of synthetic food colors, Walgreens ...
Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...